Fasudil, a Clinically Safe ROCK Inhibitor, Decreases Disease Burden in a CBL/CBL-B Deficiency-Driven Murine Model of Myeloproliferative Disorders

Hematology - United Kingdom
doi 10.1179/1607845415y.0000000031
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Informa UK Limited


Related search